Source link : https://www.newshealth.biz/health-news/new-targeted-drug-approved-for-low-grade-glioma-in-kids/
The FDA granted accelerated approval to tovorafenib (Ojemda) for children 6 months and up with relapsed or refractory low-grade glioma and BRAF-altered tumors, the agency announced on Tuesday. It represents the first systemic therapy for pediatric low-grade gliomas harboring BRAF rearrangements, or fusions, according to the agency; the drug is also indicated for tumors with […]
Author : News Health
Publish date : 2024-04-23 21:46:31
Copyright for syndicated content belongs to the linked Source.